HAVCR2 and interstitial lung disease: Cluster #26281, prevalent in DI-ILD, was marked by CD4+ with low immune-checkpoint expression (PD-1, TIM-3, TIGIT, LAG3, PD-L1, PD-L2, and OX40; Figure 2E and F).